Novo Nordisk’s Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval

2 hours ago 1

The Danish drugmaker said the accelerated support was based connected results from its Step Up trial, which showed 20.7% mean value nonaccomplishment for participants with obesity.

Read Entire Article

Novo Nordisk’s Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval

Related

Lilly’s Retatrutide Shows Significant Improvement In Weight ...

Investigation into states that mandate health insurance cove...

Hospital waiting lists in Wales see record drop

Popular

Duke, Arizona, Michigan and Florida lead title odds for Marc...

Oscars 2026: ‘One Battle After Another’ triumphs - Full resu...

Flu vaccines didn't work that well in the US, officials find...

The City That Inspired Rothko (It’s Not New York)

Air China to resume flights to North Korea at the end of the...